En tout, 40 pays utilisent ce médicament pour traiter des patients atteints de lymphomes non liés à la maladie de Hodgkin.
Some of the countries that presently have the drug are Australia, Austria, Belgium, Denmark, France, Germany, Greece, Italy, Netherlands, New Zealand, Spain, Sweden, Switzerland and the U.S. In total 40 countries can now use this drug to treat patients with non-Hodgkins lymphoma.